ADVB
Advanced Biomed Inc. Common StockNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$6.58M
P/E Ratio
—
EPS
$-5.00
Beta
—
52W High
$24.23
52W Low
$3.61
50-Day MA
$7.49
200-Day MA
$6.10
Dividend Yield
—
Profit Margin
5231.00%
Forward P/E
—
PEG Ratio
—
About Advanced Biomed Inc. Common Stock
Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies and provides them for precision oncology detection, diagnosis, and treatment in Taiwan. The company is headquartered in New York, New York.
Fundamentals
| Revenue (TTM) | 127,640 |
| Gross Profit (TTM) | 127,640 |
| EBITDA | $-6.17M |
| Operating Margin | -3856.00% |
| Return on Equity | -79.50% |
| Return on Assets | -21.30% |
| Revenue/Share (TTM) | $0.10 |
| Book Value | $7.43 |
| Price-to-Book | 1.13 |
| Price-to-Sales (TTM) | 51.52 |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $1.65M |
| Float | 777,080 |
| % Insiders | 61.41% |
| % Institutions | 1.34% |
Historical Volatility
HV 10-Day
108.32%
HV 20-Day
100.49%
HV 30-Day
92.15%
HV 60-Day
140.96%
HV Rank
—
Volatility is currently expanding
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ADVB and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 10/17/2026